Drug-Eluting Bioabsorbable Stents market

Drug-Eluting Bioabsorbable Stents Market, Global Outlook and Forecast 2022-2028

  • 10 May 2022
  • Life Sciences
  • 76 Pages
  • Report code : PMR-7062313

  • 4.7 (158)

Drug-Eluting Bioabsorbable Stents Market

Download FREE Report Sample

  Download Free sample

Drug-Eluting Bioabsorbable Stents Market contains market size and forecasts of Drug-Eluting Bioabsorbable Stents in global, including the following market information:

Global Drug-Eluting Bioabsorbable Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Drug-Eluting Bioabsorbable Stents Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Drug-Eluting Bioabsorbable Stents companies in 2021 (%)

The global Drug-Eluting Bioabsorbable Stents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Serolimus and Paclitaxel Drug-Eluting Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drug-Eluting Bioabsorbable Stents include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, Biosensors International, Terumo Corporation., MicroPort Scientific Corporation, Alvimedica and Biotronik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Drug-Eluting Bioabsorbable Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug-Eluting Bioabsorbable Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, by Type, 2021 (%)

Serolimus and Paclitaxel Drug-Eluting Stents

Sirolimus Drug Eluting Stents

Global Drug-Eluting Bioabsorbable Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, by Application, 2021 (%)

Coronary Artery Diseases

Peripheral Artery Diseases

Global Drug-Eluting Bioabsorbable Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug-Eluting Bioabsorbable Stents revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Drug-Eluting Bioabsorbable Stents revenues share in global market, 2021 (%)

Key companies Drug-Eluting Bioabsorbable Stents sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Drug-Eluting Bioabsorbable Stents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

B.Braun Melsungen

Abbott Laboratories

Boston Scientific Corporation

Biosensors International

Terumo Corporation.

MicroPort Scientific Corporation

Alvimedica

Biotronik

Elixir Medical Corporation

Innovative Health Technologies

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Drug-Eluting Bioabsorbable Stents Market

Leave This Empty: